Mead Johnson Nutrition Company (NYSE:MJN) has Predicted Move on the 7th day with Price of 83.53

33

Mead Johnson Nutrition Company (NYSE:MJN) moved up 1.49% and closed its last trading session at $71.44. This Consumer Staples Sector stock currently has the Market Capitalization of 13.23 Billion. The Average Volume for the stock is measured as 1.88 Million. The Stock has a 52-Week High of $94.4 and 52-Week Low of $65.53 following the dates, it touched its 52-Week High on Jul 26, 2016 and 52-Week Low on Jan 28, 2016. Currently, the Return on Assets value for the trailing twelve months is 12.4% with the Return on Equity and Return on Investment of -87.2% and 30.6% respectively. This firm currently has YTD (year to date) performance of 0.96 Percent which is awesome. The Short Ratio for the stock is 1.8.

Mead Johnson Nutrition Company (NYSE:MJN) Price to Earnings (P/E) ratio is 26.55. EPS or Earning per Share stands at $2.69. The TTM operating margin is 20.7 percent.

Mead Johnson Nutrition Company (NYSE:MJN) reports its Earnings on Thu 26 Jan (In 9 Days). The estimated EPS for the current quarter is said to be $0.84. Following Earnings result, share price were UP 18 times out of last 28 Qtrs. The stock has reduced about -12.1% since it reported its last earnings. The Closing price of Mead Johnson Nutrition Company (NYSE:MJN) at Last Earnings was $80.11 as compared to the previous closing price of $70.59. The Predicted Move on the 7th day after Mead Johnson Nutrition Company (NYSE:MJN) will release its earnings at about 3%.

By Looking at Earnings History, Out of 12 Quarters when the Earnings were reported, Mead Johnson Nutrition Company (NYSE:MJN) beats earnings by 75%, The Stock Missed Earnings  3  times and has met earnings  0 times.

Earnings History:

We will discuss the past Quarters Earnings below:

Mead Johnson Nutrition Company (NYSE:MJN) reported its previous quarter on 10/27/2016 where it reported the Actual Earnings of $0.87. The Closing price before the company posted its earnings was $80.11. The Stock declined on the very next day of earnings and maintained its stock price at $74.22 by showing a % change of -7.35 percent from its previous closing price. The Next Day Volume after Earnings was reported as 5.82 Million. On the 7th day After Earnings Report, the stock hit its share price as $72.74 by showing -9.2% decrease from the Stock price Before Earnings were reported.

On 07/28/2016, the stock reported the EPS of $0.88 where Analysts were projecting the EPS to be $0.78 showing a difference of $0.1. Thus Surprise Factor was there with 12.8 percent. Before Earnings Announcement on 07/28/2016, the firm had its stock price of $90.59. And immediately on the next day after earnings announcement, the stock declined -1.87% and closed its trading session at $88.9. On 7th Day after earnings release, Mead Johnson Nutrition Company (NYSE:MJN) dropped to -3.61% from $90.59 to $87.32.

On 04/28/2016, Analysts were suspecting EPS of $0.85/share where Mead Johnson Nutrition Company (NYSE:MJN) reported its Actual EPS of $0.87. Thus showing a Surprise of 2.4 percent. The Closing Price of the stock before earnings was $83.59 while on the Next day the stock closed its trading session at $86.53 with a percentage change of 3.52% from the price of 83.59 before Earnings. The Stock Closing Price on the 7th day of earnings was $83.53.

Company Profile:

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.